Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynergia Energy Regulatory News (SYN)

Share Price Information for Synergia Energy (SYN)

Share Price is delayed by 15 minutes
Get Live Data
0.0105    0.00 (0.00%)
Bid:
0.009
Ask:
0.012
Spread: 0.003 (33.333%)
Market Cap: £1.64m
SYN Live PriceLast checked at - London Stock Exchange

Intraday Synergia Energy Share Chart

Acquisition

18 Jul 2016 07:00

RNS Number : 3903E
Plastics Capital PLC
18 July 2016
 

 

 

Plastics Capital plc

(the "Company" or the "Group")

 

Acquisition of Synpac Limited

Complementary packaging acquisition for the food processing industry

 

Plastics Capital (AIM: PLA), the niche plastics products group, announces the acquisition of Synpac Limited ("Synpac") for a maximum cash consideration of £3.1 million, on a cash and debt-free basis, to be satisfied from existing debt facilities (the "Acquisition"). The Acquisition is expected to be earnings enhancing in the first full financial year following completion ¹.

 

Acquisition Highlights

· Synpac is a specialist manufacturer of vacuum bags and pouches for the food processing industry

· Complementary products and customers with the Company's existing film packaging business

· Cross-selling opportunities and cost synergies for the enlarged packaging business

· Normalised sustainable EBITDA estimated by Directors to be £0.6m

· £2.79 million cash paid on completion and a further £0.31 million is payable after 12 months

· Total cash consideration will be funded through increased debt facilities provided by Barclays Bank, as announced 4 July 2016

 

About Synpac

Established in 1984 and based in Hessle, Yorkshire, Synpac is a specialist manufacturer of high barrier, flexible packaging solutions, especially vacuum bags and pouches, for the food processing industry.

 

The Directors believe that Synpac has a loyal customer base with high levels of recurring business due to excellent service and quality standards that have been maintained over many years. As such, they believe it fits very well with the Company's Films Division comprising Flexipol Packaging Limited ("Flexipol") and Palagan Limited ("Palagan"). Flexipol, in particular, is a manufacturer of high barrier flexible packaging solutions for the food industry.

 

In the financial year ended 31 May 2015, Synpac generated revenues of £4.4 million and statutory profit before taxation of £0.8 million. The Directors estimate that the normalised sustainable EBITDA of Synpac is circa £0.6 million, after making suitable adjustment for the significant weakening of sterling post the recent referendum to leave the EU.

 

As at May 2015, Synpac had net assets of £3.0 million, including cash of £1.8 million. The fixed assets on Synpac's balance sheet included its factory and head office which was last valued at £0.7 million, which will not form part of the transaction.

 

 

Acquisition Rationale

The Acquisition is in-line with Plastics Capital's stated strategy to grow shareholder value through strategic acquisitions of related specialist plastics products businesses. The business has been followed by Plastics Capital for the last three years and is being acquired from Synpac's founder who will be retiring after an agreed handover period.

 

The Directors therefore believe that there will be minimal integration risk and the enlarged packaging business can deliver organic revenue growth in addition to increasing the operating margins of the enlarged packaging business post the Acquisition.

 

Transaction Highlights

The maximum consideration payable pursuant to the Acquisition is £3.1 million comprising:

 

· £2.79 million payable in cash on completion; and

· £0.31 million of deferred consideration payable 12 months following completion, subject to there being no warranty claims.

 

The Acquisition will be satisfied in cash through use of the recently extended existing debt facility with Barclays Bank plc.

 

Faisal Rahmatallah, Chairman of Plastics Capital, commented: "We are very pleased to announce the acquisition of Synpac Limited. Synpac is a business that meets our acquisition criteria, namely specialty products, high recurring revenues with loyal customers, limited competition and healthy financial performance. It is complementary to our other Films Division businesses and this should enable us to achieve significant synergies in due course through cross selling, operational efficiencies and cost savings."

 

 

 ¹ Any statement to the effect that the Acquisition is expected to be earnings enhancing for Plastics Capital should not be interpreted to mean that earnings per Plastics Capital ordinary share in the first full financial year following the Acquisition, nor in any subsequent period, will necessarily match or be greater than those for a preceding financial year.

 

 

 

Plastics Capital plc

Tel: 020 7978 0574

Faisal Rahmatallah, Chairman

 

Nick Ball, Finance Director

 

 

 

Cenkos Securities

Tel: 020 7397 8900

(Nomad and joint broker)

Mark Connelly

Callum Davidson

 

 

 

Allenby Capital Limited

Tel: 020 3328 5656

(Joint broker)

David Hart

 

Katrina Perez

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780/plastics@walbrookpr.com

Paul Cornelius

Mob: 07866 384 707

Helen Cresswell

Mob: 07841 917 679

 

 

Notes to Editor

Plastics Capital is a plastics products manufacturer focused on proprietary products for niche markets. The Group has five factories in the UK, one in Thailand and sales offices in the USA, Japan, China and India. Approximately 45 per cent of sales are exported to over 80 countries worldwide. Production is concentrated in the UK where significant engineering know-how and automation underpins the Group's competitiveness. The Group has approximately 490 employees.

 

 

This announcement contains inside information

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUBUNRNUABAAR
Date   Source Headline
27th May 20267:00 amRNSCambay PSC Update
12th May 20267:00 amRNSAppointment of Non-Executive Director
5th May 20267:00 amRNSCambay PSC and Board Changes
7th Apr 20267:00 amRNS$0.7m loan agreement
26th Mar 20267:00 amRNSInterim Report for the Half-Year Ended 31 Dec 2025
6th Mar 20261:52 pmRNSCambay PSC Production Update - Correction
6th Mar 20267:00 amRNSCambay PSC Production Update
9th Feb 20261:29 pmRNSCambay PSC Sale Agreement Update
22nd Jan 20267:00 amRNSCambay PSC Update
29th Dec 202511:22 amRNSResults of General Meeting
29th Dec 202511:22 amRNSResults of General Meeting
3rd Dec 20253:40 pmRNSCambay PSC Sale FAQs / Cambay PSC Update
1st Dec 202511:15 amRNSProposed Sale, cancellation of admission, & GM
1st Dec 202510:48 amRNSResults of Annual General Meeting
1st Dec 20257:00 amRNSCambay PSC SPA Signature / Cambay PSC Update
17th Nov 20259:30 amRNSCambay PSC Update
10th Nov 20251:00 pmRNSCambay PSC Update
4th Nov 20259:44 amRNSCambay PSC Update
3rd Nov 20257:00 amRNSAGM – Notice of Meeting
29th Oct 20257:00 amRNSCambay PSC Update
20th Oct 20257:00 amRNSCambay PSC Update
7th Oct 20257:00 amRNSAudited Annual Report for Year Ended 30 June 2025
16th Sep 20257:00 amRNSCambay PSC Update
27th Aug 20257:00 amRNSCambay PSC Update
4th Aug 20257:00 amRNSCambay PSC Update
21st Jul 202510:15 amRNSTR-1 Standard form notification of major holdings
8th Jul 20257:01 amRNSCambay PSC Work Program Update
8th Jul 20257:00 amRNSCorrection - Proposed Sale of Cambay PSC
4th Jul 202511:32 amRNSProposed Sale of Cambay PSC to Selan Exploration
24th Jun 202510:08 amRNSTR-1: Standard form notification of major holdings
10th Jun 20257:00 amRNSChange of Nominated Advisor
2nd Jun 20257:53 amRNSCambay PSC Update
4th Apr 202510:11 amRNSCambay PSC Update
14th Mar 20251:50 pmRNSHolding(s) in Company
13th Mar 20257:00 amRNSInterim Financial Report
24th Feb 20257:00 amRNS£750,000 Fundraise
10th Feb 20257:00 amRNSOperations Update
4th Feb 20257:00 amRNSAppointment of Executive Director
10th Jan 20257:00 amRNSChange of Joint Broker
19th Dec 20247:00 amRNSCambay Workover Update
5th Dec 20249:45 amRNSHolding(s) in Company
28th Nov 20244:00 pmRNSMedway Hub Camelot CCS Project Update
22nd Nov 20241:01 pmRNSResults of Annual General Meeting
20th Nov 20247:00 amRNSOption Exercise, Placing Update and TVR
8th Nov 20247:00 amRNSCambay Operational Update
5th Nov 20247:00 amRNSOperational Update, Equity Issue and TVR
30th Oct 20241:00 pmRNSIssue of Options
24th Oct 20247:00 amRNSAGM - Notice of Meeting
23rd Oct 202410:37 amRNSChange of Directors
14th Oct 20247:00 amRNSCambay Work Program Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.